Article

Sterile endophthalmitis following same-day intravitreal aflibercept 8 mg injections: a single-center observational study

2026-08-06

Abstract excerpt

<title>Abstract</title> <p>Background Aflibercept 8 mg was developed to extend treatment intervals in neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Although pivotal trials reported low rates of intraocular inflammation (IOI), post-marketing sterile inflammatory events have been described. We report a same-day cluster of sterile endophthalmitis after vial-drawn intravitreal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cf2c4b64-c16f-5758-8d9d-51a2963965d4
DOI: 10.21203/rs.3.rs-10541271/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sterile endophthalmitis following same-day intravitreal aflibercept 8 mg injections: a single-center observational studyDOI 10.21203/rs.3.rs-10541271/v1Read

Eighteen-Month Real-World Outcomes of Intravitreal Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A UK Single- Centre ExperienceSemantic proximity Read

Clinical care and therapeutic practice of patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) and effectiveness of faricimab in treatment-naive patients in Germany - ZEUS research projectSemantic proximity Read

Endophthalmitis Management Study- a prospective randomized clinical trial on postoperative endophthalmitis management in India: An interim analysis. EMS Report # 3Semantic proximity Read

Short-Term Efficacy of Aflibercept 8 mg in Refractory Neovascular Age-Related Macular Degeneration: A Real-World Retrospective Case Series from TaiwanSemantic proximity Read

Endogenous Fungal Endophthalmitis: Causative Organisms, Treatments, and Visual OutcomesSemantic proximity Read

Sequential switch from first-line anti-VEGF therapy to faricimab and subsequent aflibercept 8mg in treatment-resistant neovascular AMDSemantic proximity Read

Long-term Evaluation of Photo Activated Chromophore for Keratitis-Corneal Cross-linking (PACK-CXL)Semantic proximity Read

Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2mg for treatment naïve exudative age-related macular degeneration: PRECISE Study Report 7Semantic proximity Read

Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.Semantic proximity Read

Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: Guidance from a UK panel of retina specialistsSemantic proximity Read

Result of Intravitreal Aflibercept Injection for Myopic Choroidal NeovascularizationSemantic proximity Read

Removal of scleral buckle: indications, long-term outcomes and comparison with the literatureSemantic proximity Read